Carfilzomib and paclitaxel co-loaded protein nanoparticles an effective therapy against pancreatic adenocarcinomas

Medicine & Life Sciences

• carfilzomib 82%
• Human Serum Albumin 60%
• Paclitaxel 52%
• Nanoparticles 45%
• Adenocarcinoma 40%
• Proteins 19%
• Pharmacokinetics 8%
• Therapeutics 8%
• Particle Size 5%
• Drug Liberation 5%
• Evaluation Studies 5%
• Pharmaceutical Preparations 4%
• Neoplasms 3%
• Growth 2%
• In Vitro Techniques 2%

Chemical Compounds

• Carfilzomib 100%
• Paclitaxel 62%
• Nanoparticle 25%
• Protein 21%
• Pharmacokinetics 8%
• Drug 6%
• Zeta Potential 5%
• Dissolution 4%

Engineering & Materials Science

• Nanoparticles 50%
• Proteins 47%
• Pharmacokinetics 16%
• Tumors 11%
• Cytotoxicity 8%
• Zeta potential 8%
• Self assembly 7%
• Toxicity 6%
• Particle size 5%